What Is an Enterocutaneous Fistula?

An enterocutaneous fistula (ECF) is an abnormal connection that forms between the gastrointestinal tract and the skin. This allows contents from the stomach or intestines to leak onto the body’s surface. Such a connection can arise anywhere along the digestive system, from the stomach to the large bowel, manifesting as drainage from a skin opening.

Understanding Enterocutaneous Fistula

An enterocutaneous fistula’s name reflects its nature: “entero” refers to the intestine, and “cutaneous” refers to the skin. ECFs can originate from various segments of the gastrointestinal tract, including the duodenum, jejunum, ileum, colon, or rectum. The ileum, part of the small intestine, is a common site for these connections.

Fistulas are classified as either internal or external. Internal fistulas connect two internal organs or spaces within the body, such as the small bowel to the colon. An enterocutaneous fistula is an external fistula, connecting an internal organ to the outside of the body through the skin, allowing intestinal contents to drain.

Causes and Risk Factors

The development of an enterocutaneous fistula frequently follows abdominal surgery, particularly procedures involving the bowel. Surgical complications, such as a leak from an anastomotic site where two parts of the intestine were reconnected, account for a significant majority of ECF cases. Injury to the bowel wall during an operation can also lead to fistula formation.

Beyond surgical complications, inflammatory bowel diseases (IBD) like Crohn’s disease are common causes of spontaneous fistula development. The chronic inflammation associated with Crohn’s disease can erode the bowel wall, creating abnormal connections. Other causes include:
Radiation therapy
Abdominal trauma, such as stabbings or gunshot wounds
Infections leading to abscess formation
Conditions like diverticulitis, appendicitis, or perforated peptic ulcers

Several factors can increase a patient’s susceptibility to developing an ECF or hinder its healing. These include:
Malnutrition, which weakens the body’s healing and infection-fighting ability
Immunosuppression, often due to medications or underlying health conditions
Presence of foreign bodies
Certain types of cancer
Distal obstruction in the bowel

Signs, Symptoms, and Diagnosis

An enterocutaneous fistula presents with observable signs and symptoms. The most direct sign is drainage from a skin opening, which may include intestinal contents like fluid, pus, or feces. The amount, color, and odor of this drainage vary. Patients often experience abdominal pain, tenderness, and distension.

Systemic symptoms include fever, chills, dehydration, electrolyte imbalances, and significant weight loss due to fluid and nutrient loss. Malnutrition is a frequent consequence, impacting overall health and recovery.

Diagnosing an enterocutaneous fistula begins with a physical examination, where a healthcare provider inspects the skin opening and assesses for abdominal tenderness. Imaging studies are crucial for confirming the diagnosis and mapping the fistula’s anatomy.

A Computed Tomography (CT) scan with oral contrast is often a primary diagnostic tool, identifying the fistula tract, associated abscesses, or distal obstructions. A fistulogram, involving injecting contrast dye directly into the skin opening, provides detailed information about the tract’s length, extent, and connection to the bowel. Magnetic Resonance Imaging (MRI) can also be used for detailed soft tissue contrast. Laboratory tests, such as blood tests, help assess for inflammation, infection, and electrolyte imbalances.

Treatment Strategies

Managing an enterocutaneous fistula involves a comprehensive approach, often requiring medical and surgical interventions. Initial medical management focuses on stabilizing the patient. Fluid and electrolyte balance is maintained to counteract losses, often requiring intravenous fluids. Nutritional support is a cornerstone of treatment; many patients receive total parenteral nutrition (TPN), where nutrients are delivered directly into the bloodstream, especially with high-output fistulas. Enteral nutrition, delivered through a tube into the gastrointestinal tract, may also be used.

Infection control is a primary concern, with antibiotics administered to treat or prevent sepsis. Local wound care and skin protection around the fistula site are important to prevent skin breakdown and excoriation from constant exposure to digestive fluids. Medications like proton pump inhibitors or antidiarrheals may reduce fistula output. While some fistulas may close spontaneously with medical management, often within 6 to 12 weeks, many require surgical intervention.

Surgical intervention aims to close the fistula and restore gastrointestinal tract continuity. This often involves resecting the diseased bowel segment and rejoining healthy ends in an anastomosis. Surgery for ECFs is frequently complex, sometimes requiring multiple staged procedures due to inflammation, infection, or extensive adhesions. The goal is to ensure the entire bowel is functional and achieve secure abdominal wall closure. A multidisciplinary team, including surgeons, nutritionists, and wound care specialists, typically collaborates on the treatment plan.

Managing Complications and Recovery

Patients with enterocutaneous fistulas face several potential complications. Sepsis, a severe bloodstream infection, is a significant concern and a leading cause of mortality. This risk is higher if intestinal contents leak into the abdominal cavity, leading to abscess formation or generalized peritonitis. Malnutrition and severe electrolyte imbalances are also common, stemming from continuous fluid and nutrient loss.

Skin excoriation, or damage to the skin around the fistula opening, is a frequent local complication caused by irritating digestive fluids. This requires diligent wound care and specialized products to protect the skin. Extended hospital stays and complex care can also have a substantial psychological impact on patients.

Recovery from an enterocutaneous fistula can be prolonged, requiring ongoing care. Follow-up appointments are important to monitor healing, nutritional status, and overall health. Patients may need lifestyle adjustments, including dietary modifications, to support digestive health and prevent recurrence. Education about managing the fistula and potential complications is important for patients and caregivers. Support from healthcare professionals and patient support groups can help individuals navigate recovery challenges.